MR-guided vacuum-assisted breast biopsy in the management of incidental enhancing lesions detected by breast MR imaging

ObjectivesTo analyse the development of MRI-guided vacuum-assisted biopsy (VAB) in Switzerland and to compare the procedure with stereotactically guided and ultrasound-guided VAB.MethodsWe performed a retrospective analysis of VABs between 2009 and 2011. A total of 9,113 VABs were performed. Of these, 557 were MRI guided.ResultsMRI-guided VAB showed the highest growth rate (97 %) of all three procedures. The technical success rates for MRI-guided, stereotactically guided and ultrasound-guided VAB were 98.4 % (548/557), 99.1 % (5,904/5,960) and 99.6 % (2,585/2,596), respectively. There were no significant differences (P = 0.12) between the MRI-guided and the stereotactically guided procedures. The technical success rate for ultrasound-guided VAB was significantly higher than that for MRI-guided VAB (P < 0.001). There were no complications using MRI-guided VAB requiring open surgery. The malignancy diagnosis rate for MRI-guided VAB was similar to that for stereotactically guided VAB (P = 0.35).ConclusionMRI-guided VAB is a safe and accurate procedure that provides insight into clinical breast findings.Key points• Three vacuum-assisted breast biopsy (VAB) procedures were compared.• Technical success rates were high for all three VAB procedures.• Medical complications were relatively low using all three VAB procedures.• The use of MRI-guided vacuum-assisted breast biopsy is growing.

show abstract

“…The technical success rates for image-guided VABs were comparable with or superior to those previously reported [13, 20–29]. …”

Section: Discussionsupporting

confidence: 83%

MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniques

et al. 2013

View full text Add to dashboard Cite

show abstract

“…As described in the literature, the cancer detection rate of MRI-guided vacuum-assisted biopsy ranges from 17% to 61%; most studies report rates between 20% and 40%, comparable to those obtained in other types of imaging-guided biopsies ( 4 , 11 - 13 , 17 - 26 ) . The rate of technically feasible biopsies in our study was considered satisfactory (95%) and is in agreement with the 93-100% reported in other studies ( 4 , 11 - 13 , 17 - 26 ) .…”

Section: Discussionmentioning

confidence: 58%

“…We compared the results of our 205 cases with those of the samples evaluated in 14 articles published between 2001 and 2016 ( 4 , 11 - 13 , 17 - 26 ) , with lesion sample sizes ranging from 29 to 538 (Table 2).…”

Section: Discussionmentioning

confidence: 99%

Magnetic resonance imaging-guided vacuum-assisted breast biopsy: experience and preliminary results of 205 procedures

et al. 2018

View full text Add to dashboard Cite

ObjectiveTo demonstrate the frequency of malignancy and histological characteristics of lesions in patients submitted to vacuum-assisted breast biopsy guided by magnetic resonance imaging (MRI).Materials and MethodsThis was a retrospective study of MRI-guided vacuum-assisted breast biopsies performed between April 2008 and December 2016, in which we analyzed clinical and epidemiological data, as well as the BI-RADS classification and histopathological results. We compared nodules and non-nodular enhancements, in terms of their correlation with malignancy, using chi-square test.ResultsAmong 215 cases referred for MRI-guided vacuum-assisted breast biopsy, the procedure was contraindicated in 10 cases (5%) and was technically feasible in the remaining 205 (95%). Non-nodular enhancements were observed in 135 cases (66%), and nodules were observed in 70 (34%), with a mean diameter of 2.2 cm (range, 0.5-9.6 cm) and 0.97 cm (range, 0.5-2.2 cm), respectively. Of the 205 lesions analyzed, 43 (21%) were malignant, 129 (63%) were benign, and 33 (16%) were classified as high-risk lesions. The most common histological findings were invasive ductal carcinoma and, in high-risk cases, lobular neoplasia. There was no significant difference between nodules and non-nodular enhancements in terms of the rate of malignancy (p = 0.725).ConclusionIn our sample, the overall malignancy rate was 21%. However, to improve the assessment of these results, it is necessary to correlate them with the surgical data and with data from the follow-up of benign cases.

show abstract

“…Core-needle biopsy is superior to fine needle biopsy in terms of providing more material and to vacuum biopsy by being less invasive (19). Carbognin et al (20) stated that vacuum-assisted biopsy is an effective and reliable method for the diagnosis of MR-only lesions that are non-palpable and smaller than 1 cm. In a study evaluating the efficiency of vacuum-assisted biopsy system and core-needle biopsy in removing microcalcifications, the failure rate in sampling was reported as 16% for 14G needle as compared to the rate of 4% in 14G vacuum biopsy, and 1% in 11G vacuum biopsy.…”

Section: Discussionmentioning

confidence: 99%

Magnetic Resonance Imaging Guided Vacuum Assisted and Core Needle Biopsies

et al. 2016

View full text Add to dashboard Cite

MR-guided vacuum-assisted breast biopsy in the management of incidental enhancing lesions detected by breast MR imaging

Abstract: The results of this study indicate that MR-guided VAB offers good accuracy in characterising nonpalpable breast lesions visible on MR imaging alone. Small lesion size (<1 cm) did not prove to be a limitation for the success of the procedure.

Cited by 12 publications

References 19 publications

MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniques

MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniques

Magnetic resonance imaging-guided vacuum-assisted breast biopsy: experience and preliminary results of 205 procedures

Magnetic Resonance Imaging Guided Vacuum Assisted and Core Needle Biopsies

Contact Info

Product

Resources

About